Conclusion not excluding the drug discount agreement according to § 130a para. 8 SGB V by means of an open-house model for the active ingredient Infliximab for subcutaneous injection (ATC code according to WHO: L04AB02)
🔍 Key Information
📄
Tender Reference No.
102167896
📅
Publication Date
28 Oct 2026
💰
Estimated Value
N/A
🌐
Sector
N/A
📅
Deadline
30 Jun 2028
📝
Notice Type
Tenders
📍
Location
Germany
📑
Contract Duration
1 Year 8 Months 2 Days
📁
Documents & Downloads
No documents found
🏷️ CPV
No CPV found
Need help with this bid?
Our bid experts can help you find, evaluate & win more tenders.